0001576427-22-000130.txt : 20221215 0001576427-22-000130.hdr.sgml : 20221215 20221215161609 ACCESSION NUMBER: 0001576427-22-000130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221214 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WARNER JAMES CENTRAL INDEX KEY: 0001193080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36153 FILM NUMBER: 221465004 MAIL ADDRESS: STREET 1: 135 WEST 18TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Criteo S.A. CENTRAL INDEX KEY: 0001576427 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33140402290 MAIL ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 4 1 wf-form4_167113893470134.xml FORM 4 X0306 4 2022-12-14 0 0001576427 Criteo S.A. CRTO 0001193080 WARNER JAMES C/O CRITEO LEGAL DEPT. 387 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 1 0 0 0 Ordinary Shares 2022-12-14 4 M 0 20400 10.29 A 47953 D Ordinary Shares 2022-12-14 4 S 0 20400 25.90 D 27553 D Ordinary Shares 2022-12-14 4 M 0 10200 10.29 A 37753 D Ordinary Shares 2022-12-14 4 S 0 10200 25.90 D 27553 D Non-employee Warrant (right to buy) 10.29 2022-12-14 4 M 0 20400 0 D 2023-02-07 Ordinary Shares 20400.0 0 D Non-employee Warrant (right to buy) 10.29 2022-12-14 4 M 0 10200 0 D 2023-03-06 Ordinary Shares 10200.0 0 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587). For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023. Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023. Ryan Damon, as attorney-in-fact for James Warner 2022-12-15